These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
645 related articles for article (PubMed ID: 11070094)
21. Genetically engineered neural stem cells migrate and suppress glioma cell growth at distant intracranial sites. Li S; Gao Y; Tokuyama T; Yamamoto J; Yokota N; Yamamoto S; Terakawa S; Kitagawa M; Namba H Cancer Lett; 2007 Jun; 251(2):220-7. PubMed ID: 17196326 [TBL] [Abstract][Full Text] [Related]
22. Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas. Miller CR; Williams CR; Buchsbaum DJ; Gillespie GY Cancer Res; 2002 Feb; 62(3):773-80. PubMed ID: 11830532 [TBL] [Abstract][Full Text] [Related]
24. Novel treatment strategies for malignant gliomas using neural stem cells. Oh MC; Lim DA Neurotherapeutics; 2009 Jul; 6(3):458-64. PubMed ID: 19560736 [TBL] [Abstract][Full Text] [Related]
25. Structure-specific patterns of neural stem cell engraftment after transplantation in the adult mouse brain. Watson DJ; Walton RM; Magnitsky SG; Bulte JW; Poptani H; Wolfe JH Hum Gene Ther; 2006 Jul; 17(7):693-704. PubMed ID: 16839269 [TBL] [Abstract][Full Text] [Related]
26. Human adipose tissue-derived mesenchymal stem cells expressing yeast cytosinedeaminase::uracil phosphoribosyltransferase inhibit intracerebral rat glioblastoma. Altanerova V; Cihova M; Babic M; Rychly B; Ondicova K; Mravec B; Altaner C Int J Cancer; 2012 May; 130(10):2455-63. PubMed ID: 21732344 [TBL] [Abstract][Full Text] [Related]
27. Rat multipotent mesenchymal stromal cells lack long-distance tropism to 3 different rat glioma models. Bexell D; Gunnarsson S; Svensson A; Tormin A; Henriques-Oliveira C; Siesjö P; Paul G; Salford LG; Scheding S; Bengzon J Neurosurgery; 2012 Mar; 70(3):731-9. PubMed ID: 21869725 [TBL] [Abstract][Full Text] [Related]
28. Neural stem cells may be uniquely suited for combined gene therapy and cell replacement: Evidence from engraftment of Neurotrophin-3-expressing stem cells in hypoxic-ischemic brain injury. Park KI; Himes BT; Stieg PE; Tessler A; Fischer I; Snyder EY Exp Neurol; 2006 May; 199(1):179-90. PubMed ID: 16714016 [TBL] [Abstract][Full Text] [Related]
29. Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas. Herrlinger U; Woiciechowski C; Sena-Esteves M; Aboody KS; Jacobs AH; Rainov NG; Snyder EY; Breakefield XO Mol Ther; 2000 Apr; 1(4):347-57. PubMed ID: 10933953 [TBL] [Abstract][Full Text] [Related]
30. Genetically engineered human neural stem cells for brain repair in neurological diseases. Kim SU Brain Dev; 2007 May; 29(4):193-201. PubMed ID: 17303360 [TBL] [Abstract][Full Text] [Related]
31. Reelin affects chain-migration and differentiation of neural precursor cells. Massalini S; Pellegatta S; Pisati F; Finocchiaro G; Farace MG; Ciafrè SA Mol Cell Neurosci; 2009 Dec; 42(4):341-9. PubMed ID: 19698788 [TBL] [Abstract][Full Text] [Related]
32. Developing Bioinspired Three-Dimensional Models of Brain Cancer to Evaluate Tumor-Homing Neural Stem Cell Therapy. Carey-Ewend AG; Hagler SB; Bomba HN; Goetz MJ; Bago JR; Hingtgen SD Tissue Eng Part A; 2021 Jul; 27(13-14):857-866. PubMed ID: 32907497 [TBL] [Abstract][Full Text] [Related]
33. Homing properties of adipose-derived stem cells to intracerebral glioma and the effects of adenovirus infection. Lamfers M; Idema S; van Milligen F; Schouten T; van der Valk P; Vandertop P; Dirven C; Noske D Cancer Lett; 2009 Feb; 274(1):78-87. PubMed ID: 18842332 [TBL] [Abstract][Full Text] [Related]
34. Human NT2 neural precursor-derived tumor-infiltrating cells as delivery vehicles for treatment of glioblastoma. Zhao Y; Wang S Hum Gene Ther; 2010 Jun; 21(6):683-94. PubMed ID: 20113165 [TBL] [Abstract][Full Text] [Related]
35. Double suicide gene therapy using human neural stem cells against glioblastoma: double safety measures. Lee JY; Lee DH; Kim HA; Choi SA; Lee HJ; Park CK; Phi JH; Wang KC; Kim SU; Kim SK J Neurooncol; 2014 Jan; 116(1):49-57. PubMed ID: 24113876 [TBL] [Abstract][Full Text] [Related]
36. Primary gene-engineered neural stem/progenitor cells demonstrate tumor-selective migration and antitumor effects in glioma. Mercapide J; Rappa G; Anzanello F; King J; Fodstad O; Lorico A Int J Cancer; 2010 Mar; 126(5):1206-15. PubMed ID: 19653275 [TBL] [Abstract][Full Text] [Related]
37. The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma. Ehtesham M; Kabos P; Kabosova A; Neuman T; Black KL; Yu JS Cancer Res; 2002 Oct; 62(20):5657-63. PubMed ID: 12384520 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of neuronal nitric oxide synthase activity promotes migration of human-induced pluripotent stem cell-derived neural stem cells toward cancer cells. Chen C; Wang Y; Goh SS; Yang J; Lam DH; Choudhury Y; Tay FC; Du S; Tan WK; Purwanti YI; Fan W; Wang S J Neurochem; 2013 Aug; 126(3):318-30. PubMed ID: 23406356 [TBL] [Abstract][Full Text] [Related]
39. Combined treatment of tumor-tropic human neural stem cells containing the CD suicide gene effectively targets brain tumors provoking a mild immune response. Lee SJ; Kim Y; Jo MY; Kim HS; Jin Y; Kim SU; Jin J; Joo KM; Nam DH Oncol Rep; 2011 Jan; 25(1):63-8. PubMed ID: 21109958 [TBL] [Abstract][Full Text] [Related]
40. Neural precursor cells as carriers for a gene therapeutical approach in tumor therapy. Arnhold S; Hilgers M; Lenartz D; Semkova I; Kochanek S; Voges J; Andressen C; Addicks K Cell Transplant; 2003; 12(8):827-37. PubMed ID: 14763502 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]